NATIONAL HEALTH INVESTORS INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $375.6M | $335.2M | $319.8M | $278.2M | $298.7M |
| Operating expenses | $239.0M | $211.9M | $200.9M | $241.9M | $216.1M |
| Interest expense | $57.4M | $59.9M | $58.2M | $44.9M | $50.8M |
| Net income | $142.2M | $138.0M | $135.7M | $66.4M | $111.8M |
| Balance Sheet | |||||
| Cash and equivalents | $19.6M | $24.3M | $22.3M | $19.3M | $37.4M |
| Total assets | $2.8B | $2.6B | $2.5B | $2.5B | $2.8B |
| Total liabilities | $1.3B | $1.2B | $1.2B | $1.2B | $1.3B |
| Total debt | $1.2B | $1.1B | $1.1B | $1.1B | $1.2B |
| Stockholders' equity | $1.5B | $1.4B | $1.3B | $1.3B | $1.5B |
| Cash Flow Statement | |||||
| Cash from operations | $236.6M | $207.8M | $184.4M | $185.3M | $210.9M |
| Depreciation and amortization | $80.9M | $71.4M | $70.0M | $70.9M | $80.8M |
| Stock-based compensation | $5.6M | $4.2M | $4.6M | $8.6M | $8.4M |
| Capital expenditure | $294.0M | $157.9M | $49.6M | $11.0M | $50.3M |
| Free cash flow | -$57.5M | $49.8M | $134.9M | $174.3M | $160.5M |
| Dividends paid | $169.7M | $156.5M | $156.2M | $161.8M | $182.9M |
| Share repurchases | — | $0 | $0 | $152.0M | $0 |
| Impairments | — | — | — | — | $51.8M |
Shares outstanding 48.5M · Free float 86.4%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.